File size: 236 Bytes
db5a285 |
1 2 3 4 5 6 |
JKB-122 JKB-122 is an investigational small molecule, long-acting toll-like receptor 4 (TLR4) antagonist developed for autoimmune hepatitis and nonalcoholic fatty liver disease. The drug was transferred to Biostax in 2022. References |